Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CTI Bags Cash, Turns Its Back On Zevalin

Mar 16 2009

• By Emily Hayes

Related Content

CTI Makes Over Zevalin As Front-Line NHL Therapy Booster

Dec 03 2008

Cephalon’s Treanda Approved For Indolent Non-Hodgkin’s Lymphoma

Oct 31 2008

Broader Zevalin NHL Label: 18 Times More Use?

Oct 02 2008

CTI Plans Label Expansion For Zevalin After Acquiring The NHL Drug From Biogen

Aug 16 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window